Comprehensive Model Context Protocol server for managing Home Assistant through AI assistants.
Nothing to run from here
Coverage Rights is installed from its publisher's own source and answers where it runs, so this marketplace is not in the path of a single call. There is no address here to send one to, and a panel that pretended otherwise would be showing you an answer we made up. Install it and call it from your own client — the Installation tab has the entry for each one.
9
tools declared
—
trust score
remote
at its publisher
—
calls last 7d
What it does
Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.
Quickstart
# 1 — add it to Claude Code
claude mcp add --scope user --transport http coverage-rights-mcp https://www.coverage-rights.com/api/mcp
# 2 — ask your agent for something these tools do
# list_insurers, get_insurer_metrics, rank_denial_rates and 6 more
Coverage Rights costs nothing on mcprush: there is no plan to choose here, no cap to set and nothing mcprush can bill you for.
Publishernot claimed
CRAll 1 server
coverage-rights1 server
1 category
Collected from a public index. Nobody has claimed this account, so nothing here was written by its author — claim it if it is yours.
Installation
Where are you running it?
Every route below installs the same thing and ends at the same approval screen. Nothing here runs on your machine and nothing runs on ours: this server answers at its publisher’s own address, and what you install is the connection straight to it.
Claude Codedeclared by this listing
This is a public server: it answers at its publisher’s own address and this marketplace is not in the path. Claude Code registers it in one command; --scope user makes it available in every project. The transport below is http, as the publisher's own manifest declares it.
claude mcp add --scope user --transport http coverage-rights-mcp https://www.coverage-rights.com/api/mcpReconnect, or start a new session, and the tools appear in the model’s tool list.
Free on mcprush, and it answers at its publisher’s own address: this marketplace is not in the path, so there is no key of ours to hold and no card to add.
What it writes
One config entry pointing straight at the publisher’s own address — this marketplace is not in the path, and nothing from this listing executes on your machine.
What you approve
9 tools, with what each one reads, writes and reaches shown before you agree — the same list on every route above. Read the tool surface.
Tool surface
What the model actually sees. Descriptions are diffed on every release — see version history.
List tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each.
No parameter schema on file.
Get an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| slug | string | yes | Insurer slug from list_insurers, e.g. 'unitedhealthcare' |
Insurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts.
No parameter schema on file.
External-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy').
| Parameter | Type | Required | Notes |
|---|---|---|---|
| slug | string | yes | Treatment slug, e.g. 'zepbound', 'pharmacy', 'speech-therapy'. Use search_outcomes to find slugs. |
External-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| slug | string | yes | Condition slug, e.g. 'obesity', 'autism', 'hepatitis-c' |
Search treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| query | string | yes | Search text, e.g. 'wegovy', 'back pain', 'imaging' |
| limit | integer | no | Max results per type (default 10) |
Deterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, TRICARE, and unknown coverage; unsupported or ambiguous routes fail closed.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| program | string | yes | Plan type |
| denial_reason | string | yes | Denial reason category. Use 'prescription-drug' for medication denials — formulary exclusion, step therapy, quantity limits, or drug prior authorization — which return the formulary-exception grounds |
| state | string | no | Two-letter state code, e.g. 'ca' |
| insurer_slug | string | no | Insurer slug for insurer-specific stats |
| employer_type | string | no | Required to resolve job-based coverage |
| funding_status | string | no | Required to resolve job-based state versus federal governance |
| drug_channel | string | no | For a drug denial, whether the medical or pharmacy benefit applies |
| regulatory_marker | string | no | — |
| regulatory_state_basis | string | no | — |
| appeal_stage | string | no | — |
| current_status | string | no | — |
Drug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that specific drug, what winning appeals argue, and the step-therapy exception framing — plus the publishe
| Parameter | Type | Required | Notes |
|---|---|---|---|
| drug | string | yes | Brand or generic drug name, e.g. 'Zepbound', 'ustekinumab' |
How a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list.
| Parameter | Type | Required | Notes |
|---|---|---|---|
| state | string | yes | Two-letter state code, e.g. 'ca', 'ny', 'fl' |
Free
$0 forever
- Every tool — any call limit is its publisher’s, not ours
- No card, and mcprush charges nothing for it
- Runs at its publisher’s own address — this marketplace is not in the path
- Nothing to cap, because mcprush bills nothing
What counts against your monthly calls
| Tool | Unit | Calls used | Out of the allowance |
|---|
Nothing here is billable: mcprush charges nothing to install Coverage Rights or to call it, at any volume.
Call allowance · this installenforced at the gateway
Monthly allowance, in calls
—
—
Alert at 80% · then the tool returns a normal MCP error
Used this month: —
—Grade not published
No rule-by-rule report on file for this release
Two independent axes, because powerful and malicious are different questions. The grade is threat only. The capability level is blast radius, and it is never a penalty on the grade — it is priced as one subtract-only term in the score, where you can see it.
This listing is an address its publisher runs, and you connect to it directly — this marketplace is not in the path. The scanner reads packages and public source, and an address is neither. So there is no grade — not a withheld one, an unmeasured one.
Release history
This is an address its publisher runs: which release it serves is theirs to choose, so there is nothing here to pin. The history below is for reading; the current release on file is 1.1.0.
1.1.0
undated
latestNo release note was published with this version.
—
no reviews yet
Who can review
One review per account, from a signed-in account that does not publish this listing. Nothing else is asked — you can say what you think before you install it. Publishers can reply once per review, and a review can be edited or deleted by whoever wrote it.
Sign in to write one
Any signed-in account that does not publish Coverage Rights can review it, once — before installing it or after. A review from an account that has installed it is marked as one.
No reviews yet
Nobody has reviewed this listing. The rating on the card is the mean of the reviews written here and nothing else, so there is no rating until somebody writes the first — which takes a signed-in account that does not publish it, and nothing else.